- Jan 26, 2021
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma
Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively kills cancer cells. Read more: https://www.news-medical.net/news/20210122/Modified-version-of-CAR-T-cell-therapy-shows-promise-in-targeting-neuroblastoma.aspx
- Jan 25, 2021
Landmark research toward increasing survival rates for aggressive childhood cancer
A new combination of drugs could help to increase survival rates with fewer side effects for some children with one of the most aggressive forms of childhood brain cancer. Read more: https://medicalxpress.com/news/2021-01-landmark-survival-aggressive-childhood-cancer.html
- Jan 22, 2021
FDA Approves Crizotinib for Pediatric ALK+ ALCL Indication
Crizotinib—a tyrosine kinase inhibitor with activity against ALK, ROS1, and MET—was granted FDA approval for use in pediatric patients with relapsed or refractory ALK-positive anaplastic large cell lymphoma. Read more: https://www.cancernetwork.com/view/fda-approves-crizotinib-for-pediatric-alk-alcl-indication
- Jan 7, 2021
Drug combination increases susceptibility to chemotherapy in cases of severe neuroblastoma
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs. Read more: https://www.eurekalert.org/pub_releases/2021-01/uog-dci010721.php
- Jan 6, 2021
Fermanagh scientist leads breakthrough on childhood cancer research
A scientist from Kinawely now based in Amsterdam has led a breakthrough discovery in childhood cancer research. Dr. Caitrín Crudden is a Marie Curie Postdoctoral Research Fellow at the Amsterdam University Medical Centre, specialising in molecular and cell biology. Her work focuses on childhood sarcomas, which sees cancer cells begin growing in the soft tissue in a child's body. Read more: https://www.impartialreporter.com/news/18979148.fermanagh-scientist-leads-breakthroug
- Jan 5, 2021
Parents' finances differently affected by having a child diagnosed with cancer
Mothers and fathers of children diagnosed with cancer are affected financially in different ways. While mothers' incomes fall in the short term and then rise, the adverse financial repercussions on fathers occur later. Read more: https://www.eurekalert.org/pub_releases/2021-01/uu-pfd010421.php